Scinai Immunotherapeutics (SCNI) Total Liabilities (2024 - 2025)

Scinai Immunotherapeutics (SCNI) has disclosed Total Liabilities for 2 consecutive years, with $3.5 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 1.5% to $3.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.5 million through Dec 2025, up 1.5% year-over-year, with the annual reading at $3.5 million for FY2025, 1.5% up from the prior year.
  • Total Liabilities hit $3.5 million in Q4 2025 for Scinai Immunotherapeutics, up from $3.5 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $3.5 million in Q4 2025 to a low of $3.5 million in Q4 2024.